Cite
Anticancer effects of the nitric oxide-modified saquinavir derivative saquinavir-NO against multidrug-resistant cancer cells.
MLA
Rothweiler, Florian, et al. “Anticancer Effects of the Nitric Oxide-Modified Saquinavir Derivative Saquinavir-NO against Multidrug-Resistant Cancer Cells.” Neoplasia (New York, N.Y.), vol. 12, no. 12, Dec. 2010, pp. 1023–30. EBSCOhost, https://doi.org/10.1593/neo.10856.
APA
Rothweiler, F., Michaelis, M., Brauer, P., Otte, J., Weber, K., Fehse, B., Doerr, H. W., Wiese, M., Kreuter, J., Al-Abed, Y., Nicoletti, F., & Cinatl, J., Jr. (2010). Anticancer effects of the nitric oxide-modified saquinavir derivative saquinavir-NO against multidrug-resistant cancer cells. Neoplasia (New York, N.Y.), 12(12), 1023–1030. https://doi.org/10.1593/neo.10856
Chicago
Rothweiler, Florian, Martin Michaelis, Peter Brauer, Jürgen Otte, Kristoffer Weber, Boris Fehse, Hans Wilhelm Doerr, et al. 2010. “Anticancer Effects of the Nitric Oxide-Modified Saquinavir Derivative Saquinavir-NO against Multidrug-Resistant Cancer Cells.” Neoplasia (New York, N.Y.) 12 (12): 1023–30. doi:10.1593/neo.10856.